VR Logo

Unrated

DSP Healthcare Fund - Regular Plan


1 Lakh

Investment Grown to
₹ 2.25 Lakh

₹ 10000

Monthly SIP Grown to
₹ 5.93 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund -2.98 -0.59 -0.26 1.68 -1.28 3.37 16.71 31.09 -- -- --
S&P BSE Healthcare TRI -1.67 -0.50 0.52 2.02 -2.52 -0.83 16.19 23.15 -- -- --
Equity: Sectoral-Pharma -1.64 -0.47 0.63 2.39 -2.41 -0.39 15.18 27.47 -- -- --
Rank within category 15 11 15 13 5 2 3 2 -- -- --
Number of funds in category 15 15 15 15 13 13 10 7 4 3 3

As on 14-Jan-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 16.71 31.09 -- 2.18% 1,442
Nippon India Pharma Fund
Unrated
Jun-04 16.73 26.26 17.94 1.95% 5,397
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 13.63 27.67 -- 2.13% 2,964
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 13.98 23.83 11.80 2.10% 1,943
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 23.58 31.73 -- 2.06% 1,935

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 15.03 01-Apr-2020 - 09-Apr-2020 -12.84 11-Mar-2020 - 18-Mar-2020
Month 28.49 23-Mar-2020 - 22-Apr-2020 -21.90 20-Feb-2020 - 23-Mar-2020
Quarter 42.17 23-Mar-2020 - 22-Jun-2020 -9.28 23-Dec-2019 - 23-Mar-2020
Year 94.07 23-Mar-2020 - 23-Mar-2021 -5.69 22-Mar-2019 - 23-Mar-2020

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 30.11 16.74 1.58 2.96 0.72 11.66
S&P BSE Healthcare TRI 24.04 21.45 0.95 1.89 -- --
Equity: Sectoral-Pharma 27.24 19.26 1.23 2.54 0.87 5.78
Rank within category 2 1 1 1 1 1
Number of funds in category 7 7 7 7 7 7

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Dec-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 24
Top 10 Stocks (%) 66.96
Top 5 Stocks (%) 41.37
Top 3 Sectors (%) 95.92
Portfolio P/B Ratio 5.14
Portfolio P/E Ratio 39.79

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 41,227 57,163
Giant (%) 17.98 16.30
Large (%) 25.84 39.85
Mid (%) 36.31 37.16
Small (%) 19.87 6.60
Tiny (%) -- 0.69

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 32.82 14.33 0.00 11.93
down Max Healthcare Institute Healthcare 84.57 8.66 0.00 8.66
equal Cipla Healthcare 28.39 9.58 0.00 7.96
equal Apollo Hospitals Healthcare 68.09 8.13 1.69 6.89
equal Ipca Laboratories Healthcare 27.44 11.48 5.70 5.93
equal Procter & Gamble Health Healthcare 48.57 6.13 2.85 5.88
equal Dr. Reddy's Lab Healthcare 39.65 10.41 5.12 5.70
equal Lupin Healthcare -- 8.03 0.00 5.67
equal Alkem Laboratories Healthcare 25.11 5.10 1.54 4.22
equal Vijaya Diagnostic Centre Healthcare 65.72 4.24 0.00 4.12
equal Indoco Remedies Healthcare 30.71 5.43 2.22 3.54
equal Intuitive Surgical Inc. (USA) Healthcare -- 3.52
down Narayana Hrudayalaya Healthcare 45.60 3.12 0.00 2.80
equal Globus Medical Inc Healthcare -- 2.51
equal Abiomed Inc Healthcare -- 2.49
equal ICICI Lombard General Insurance Company Insurance 55.90 3.77 1.17 2.35
equal Abbott Laboratories Healthcare -- 2.31
equal Syngene International Healthcare 61.51 3.77 1.79 2.00
up Aarti Drugs Healthcare 22.94 5.29 1.12 1.77
equal Alembic Pharmaceuticals Healthcare 17.93 3.90 1.20 1.51
new Medplus Health Services Healthcare 226.05 1.38 0.00 1.38
equal Kovai Medical Center Healthcare 19.03 1.19 0.00 1.17
equal Unichem Laboratories Healthcare -- 4.31 1.00 1.13
new Illumina Inc. (USA) Engineering -- 0.48
new Global X Genomics & Biotechnology ETF Financial -- 0.44

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Dec-2021

Fund Manager

— Chirag Dagli since 01-Dec-2020

Education: Mr. Dagli has done B. COM and Chartered Accountant.

Experience: Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.

— Vinit Sambre since 12-Nov-2018

Education: Mr. Sambre is a B.Com and FCA.

Experience: Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999).

Interviews:

Funds Managed:


-0.59%

Change from previous, NAV as on 14-Jan-2022

Growth: ₹ 23.0590

IDCW: ₹ 20.7860


Investment Strategy

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Investment Details

Min. Investment (₹) 500
Min. Addl Investment (₹) 500
Min. SIP Investment (₹) 500
Min. No of Cheques 12
Min. Withdrawal (₹) 500
Min. Balance (₹) 500
Lock-in Period Not Applicable
Exit Load 1% for redemption within 364 days

Basic Details

Fund House: DSP Mutual Fund
Launch Date: 30-Nov-2018
Return Since Launch: 30.64%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,442 Cr (As on 31-Dec-2021)
Expense: 2.18% (As on 31-Dec-2021)
Risk Grade: --
Return Grade: --
Turnover: 19.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW25-Mar-20211.8400

Contact Information

AMC: DSP Investment Managers Pvt. Ltd.

Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai - 400069

Phone: 022-66178000

Fax: 022-56578181

Website: https://www.dspim.com/

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

Investment ideas for 2022

DateFriday, 21-Jan-2022
Time12:30 PM - 01:00 PM

attending You have reserved a spot